Voluntary recall of EpiPen expanded

The voluntary recall of select lots of EpiPen Auto-Injectors and EpiPen Jr devices has been expanded.

The products are now being recalled in the U.S. and other markets.

Mylan NV and its manufacturing partner Meridian Medical Technologies added lots distributed in the U.S. to the voluntary recall. The recall stems from a defect in the device, which could make the injector difficult to activate in an emergency. Although the defect appears to be rare, the recall is being expanded as a precautionary measure, according to an announcement.

The affected lots were manufactured by Meridian, a Pfizer company, and distributed by Mylan Specialty between December 2015 and July 2016. The recall does not include the generic versions of the EpiPen.

Patients can find the recalled product NDC numbers, lot numbers and expiration dates here. If the EpiPen is part of the recall, a free voucher for a replacement EpiPen or generic equivalent device and a prepaid package to return the recalled device to Stericycle will be provided.  

The epinephrine injection devices are used in cases of severe allergic reactions resulting in anaphylaxis. A delay in applying epinephrine can have life-threatening consequences. Sensitive individuals may have severe reactions to bee stings, peanuts or other allergens.